Prevention and treatment of injection-site sarcomas

Journal of Feline Medicine and Surgery

Volumn 3, Issue 4, 2001, Pages 169-170

  Macy, D W ^a   Guillermo Couto, C ^b,c  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM DERIVATIVE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INACTIVATED VACCINE; MITOXANTRONE; RABIES VACCINE; VACCINE; VINCRISTINE; VINCRISTINE SULFATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DRUG ADMINISTRATION ROUTE; FELINE LEUKEMIA VIRUS; IATROGENIC DISEASE; INJECTION; INJECTION SITE; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; SKIN TUMOR; SOFT TISSUE SARCOMA; TUMOR BIOPSY; UNITED STATES; VACCINATION; VETERINARY MEDICINE;

ANIMALIA; FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS;

EID: 0035194997     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1053/jfms.2001.0145     Document Type: Article

References (4)

1. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992)
2. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats
3. Vaccine-site associated sarcomas in cats: Clinical experience and a laboratory review (1982-1993)
4. Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus, and calicivirus vaccine